218 related articles for article (PubMed ID: 2988259)
21. The effect of various corticotropin-releasing factor trains on the release of adrenocorticotropin, beta-endorphin, and beta-lipotropin from perifused ovine pituitary cells.
Evans MJ; Brett JT; McIntosh RP; McIntosh JE; Roud HK; Livesey JH; Donald RA
Endocrinology; 1985 Sep; 117(3):893-9. PubMed ID: 2990876
[TBL] [Abstract][Full Text] [Related]
22. A pituitary tumor producing high molecular weight adrenocorticotropin-related peptides: clinical and cell culture studies.
Fuller PJ; Lim AT; Barlow JW; White EL; Khalid BA; Copolov DL; Lolait S; Funder JW; Stockigt JR
J Clin Endocrinol Metab; 1984 Jan; 58(1):134-42. PubMed ID: 6315755
[TBL] [Abstract][Full Text] [Related]
23. Multiple forms of immunoreactive beta-endorphin are present in an ectopic adrenocorticotropin-producing tumor but not in normal pituitary or pituitary adenomas.
Suda T; Tozawa F; Yamaguchi H; Shibasaki T; Demura H; Shizume K
J Clin Endocrinol Metab; 1982 Jan; 54(1):167-71. PubMed ID: 6274895
[TBL] [Abstract][Full Text] [Related]
24. Plasma ACTH-response to the corticotropin releasing factor in patients with Cushing's disease. Comparison with the lysine-vasopressin test.
Catania A; Cantalamessa L; Orsatti A; Mosca G; Minonzio F; Motta P; Reschini E; Zanussi C
Metabolism; 1984 May; 33(5):478-81. PubMed ID: 6325850
[TBL] [Abstract][Full Text] [Related]
25. Discordances in the temporal pattern of the ACTH/beta-endorphin releasing effects of synthetic CRFs and partially purified bovine CRF in a superfusion system.
Yasuda Y; Yasuda N
Horm Metab Res; 1986 May; 18(5):313-7. PubMed ID: 3013743
[TBL] [Abstract][Full Text] [Related]
26. Regulation of the seasonal cycle of beta-endorphin and ACTH secretion into the peripheral blood of rams.
Ssewannyana E; Lincoln GA; Linton EA; Lowry PJ
J Endocrinol; 1990 Mar; 124(3):443-54. PubMed ID: 2159047
[TBL] [Abstract][Full Text] [Related]
27. Synthetic corticotropin-releasing factor stimulates secretion of immunoreactive beta-endorphin/beta-lipotropin and ACTH by human fetal pituitaries in vitro.
Gibbs DM; Stewart RD; Vale W; Rivier J; Yen SS
Life Sci; 1983 Jan; 32(5):547-50. PubMed ID: 6296594
[TBL] [Abstract][Full Text] [Related]
28. ACTH response to desmopressin in a patient with acromegaly; expression of corticotropin-releasing factor, urocortins and vasopressin V1b receptor in GH-producing pituitary adenoma.
Arihara Z; Sakurai K; Osaki Y; Fukazawa H; Yamada S; Inoshita N; Murakami O; Ohba K; Takahashi K
Endocr J; 2011; 58(12):1029-36. PubMed ID: 21908929
[TBL] [Abstract][Full Text] [Related]
29. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.
Chrousos GP; Schulte HM; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
N Engl J Med; 1984 Mar; 310(10):622-6. PubMed ID: 6319991
[TBL] [Abstract][Full Text] [Related]
30. Evidence for an ultradian secretion of adrenocorticotropin, beta-endorphin and alpha-melanocyte-stimulating hormone by the ovine anterior and intermediate pituitary.
Engler D; Pham T; Fullerton MJ; Clarke IJ; Funder JW
Neuroendocrinology; 1989 Apr; 49(4):349-60. PubMed ID: 2541359
[TBL] [Abstract][Full Text] [Related]
31. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
[TBL] [Abstract][Full Text] [Related]
32. Ovine (o) and human (h) corticotrophin releasing factor (CRF) in man: CRF-stimulation and CRF-immunoreactivity.
Stalla GK; Hartwimmer J; von Werder K; Müller OA
Acta Endocrinol (Copenh); 1984 Jul; 106(3):289-97. PubMed ID: 6331035
[TBL] [Abstract][Full Text] [Related]
33. Studies on the glucocorticoid-receptor blocking action of RU 38486 in cultured ACTH-secreting human pituitary tumour cells and normal rat pituitary cells.
Lamberts SW; Bons EG; Uitterlinden P
Acta Endocrinol (Copenh); 1985 May; 109(1):64-9. PubMed ID: 2988258
[TBL] [Abstract][Full Text] [Related]
34. Differential release of proopiomelanocortin-derived peptides from the human pituitary: evidence from a panel of two-site immunoradiometric assays.
Gibson S; Crosby SR; Stewart MF; Jennings AM; McCall E; White A
J Clin Endocrinol Metab; 1994 Apr; 78(4):835-41. PubMed ID: 8157708
[TBL] [Abstract][Full Text] [Related]
35. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations.
Peterson ME; Orth DN; Halmi NS; Zielinski AC; Davis DR; Chavez FT; Drucker WD
Endocrinology; 1986 Aug; 119(2):720-30. PubMed ID: 3015556
[TBL] [Abstract][Full Text] [Related]
36. The effect of naloxone on ATCH and beta-endorphin in patients with Cushing's disease.
Baranowska B; Dorobek W; Misiorowski W; Jeske W; Abdel-Fattah MH
Acta Endocrinol (Copenh); 1985 Oct; 110(2):170-5. PubMed ID: 2998130
[TBL] [Abstract][Full Text] [Related]
37. Pituitary microadenomas causing Cushing's disease respond to corticotropin-releasing factor.
Orth DN; DeBold CR; DeCherney GS; Jackson RV; Alexander AN; Rivier J; Rivier C; Spiess J; Vale W
J Clin Endocrinol Metab; 1982 Nov; 55(5):1017-9. PubMed ID: 6288750
[TBL] [Abstract][Full Text] [Related]
38. Effects of synthetic corticotropin-releasing factor in normal individuals and in patients with hypothalamic-pituitary-adrenocortical disorders.
Jørgensen H; Skare S; Frey H; Hanssen KF; Norman N
Acta Med Scand; 1985; 218(1):79-84. PubMed ID: 2996312
[TBL] [Abstract][Full Text] [Related]
39. Circulating adrenomedullin is increased in patients with corticotropin-dependent Cushing's syndrome due to pituitary adenoma.
Letizia C; Di Iorio R; De Toma G; Marinoni E; Cerci S; Celi M; Subioli S; D'Erasmo E
Metabolism; 2000 Jun; 49(6):760-3. PubMed ID: 10877203
[TBL] [Abstract][Full Text] [Related]
40. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
